Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Biological cost associated with fosfomycin resistance in Escherichia coli isolates from urinary tract infections].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 1 Jun 2007

Alós J I, García-Peña P, Tamayo J

Abstract excerpt

Resistance to fosfomycin develops rapidly in experimental conditions, although despite its frequent use in UTI, resistance in E. coli, the main uropathogen, is very low (1-3%), and has remained so for many years. The objective of this study was to ascertain whether E. coli fosfomycin-resistant st...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colony Count, Microbial
Share to Drug Resistance, Bacterial
Share to Drug Resistance, Multiple, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Escherichia coli Infections

Share to Fermentation

Share to Fosfomycin

Share to Lactose

Share to Urinary Tract Infections

Source

Identifiers

PMID: 17893758

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17893758-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Biological cost associated with fosfomycin resistance in Escherichia coli isolates from urinary tract infections].PMID 17893758Read ↗

Biological costs and mechanisms of fosfomycin resistance in Escherichia coli.Semantic proximity Read ↗

Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.Semantic proximity Read ↗

[The cost of antibiotic resistance: analysis and consequences].Semantic proximity Read ↗

Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.Semantic proximity Read ↗

Fitness costs associated with the acquisition of antibiotic resistance.Semantic proximity Read ↗

[Mechanism of fosfomycin-resistance in clinical isolates].Semantic proximity Read ↗

Molecular insights into fosfomycin resistance in Escherichia coli.Semantic proximity Read ↗

Phenotypic changes associated with the fitness cost in antibiotic resistant Escherichia coli strains.Semantic proximity Read ↗

[The resistance to antibiotics and chemotherapeutics in bacteria (author's transl)].Semantic proximity Read ↗

No apparent costs for facultative antibiotic production by the soil bacterium Pseudomonas fluorescens Pf0-1.Semantic proximity Read ↗

Fitness cost of chromosomal drug resistance-conferring mutations.Semantic proximity Read ↗

[Frequency of recombination exchanges in Escherichia coli K-12: genetic determinants controlling this frequency].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.